The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three-year highs in response to breakthrough innovations and increased deals for biotech...
Read more2025 is poised to be a pivotal year for the robotics industry, driven by the integration of artificial intelligence (AI)....
Read moreIn today’s digital world, cybersecurity is not just important — it’s essential. The alarming rise in cyberattacks is fueling the...
Read more(TheNewswire) Noble Mineral Exploration Inc. (‘ Noble ‘ or the ‘ Company ‘) (TSXV: NOB) (OTCQB: NLPXF) is pleased to...
Read moreGraphene is often heralded as the “wonder material” of the 21st century, and investing in graphene companies offers investors exposure...
Read more(TheNewswire) VANCOUVER, BC TheNewswire – January 7, 2025 Heritage Mining Ltd. (CSE: HML FRA:Y66) (‘Heritage’ or the ‘Company’) is pleased...
Read moreCanadian markets showed mixed reactions following Prime Minister Justin Trudeau’s resignation. The S&P/TSX Composite Index (INDEXTSI:OSPTX) closed lower on Monday...
Read moreSecurity is becoming a growing global concern, both online and off. Diverse companies are stepping up to provide solutions for...
Read moreMajor miner Barrick Gold (TSX:ABX,NYSE:GOLD) remains unable to export gold from its Loulo-Gounkoto mining complex in Mali due to ongoing...
Read morePerpetua Resources (TSX:PPTA,NASDAQ:PPTA) has secured final approval from the US Forest Service (USFS) for its Stibnite gold project in Idaho,...
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved